Integer (NYSE:ITGR) Releases Earnings Results, Beats Expectations By $0.01 EPS

Integer (NYSE:ITGR) announced its quarterly earnings results on Thursday. The medical equipment provider reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.01, FiscalAI reports. The business had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. Integer’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the company posted $1.31 EPS. Integer updated its FY 2026 guidance to 5.830-6.400 EPS.

Here are the key takeaways from Integer’s conference call:

• Q1 results were in line with guidance — sales of $440 million (reported +0.5%, organic +1.3%) and adjusted EPS of $1.20, but adjusted operating margin fell 230 bps to 13.9% and adjusted EBITDA declined to $85 million due largely to lower fixed-cost absorption.
• Management cut its 2026 outlook — reported sales now expected to be down 1%–3% (to $1.805B–$1.835B), organic sales flat to down 1% (with a persistent 3%–4% headwind from three new products), and adjusted EPS guided to $5.83–$6.40.
• The board has launched a strategic review to explore options to maximize shareholder value amid heightened interest, while noting no timeline or assurance a transaction will occur.
• Management is implementing near-term cost actions while protecting new-product investments, expects sequential margin improvement through 2026, and forecasts free cash flow of $85M–$105M with year-end net total debt around $1,185M–$1,205M and leverage within its 2.5–3.5x target.

Integer Stock Performance

ITGR stock traded up $5.63 during midday trading on Thursday, reaching $89.30. 2,190,673 shares of the company were exchanged, compared to its average volume of 743,541. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. The business has a 50-day moving average price of $85.94 and a two-hundred day moving average price of $81.71. Integer has a one year low of $62.00 and a one year high of $127.06. The firm has a market capitalization of $3.04 billion, a price-to-earnings ratio of 31.11, a price-to-earnings-growth ratio of 1.44 and a beta of 0.71.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q1 sales beat street expectations and showed modest organic growth; revenue was about $440M (up 0.5% year/year) which topped some analyst estimates and supports near-term top-line momentum. Integer Holdings Corporation Reports First Quarter 2026 Results
• Positive Sentiment: The Board has launched a formal strategic review to evaluate a full range of options (sale, merger, strategic combination or standalone alternatives) — an action that can surface takeover interest or other transactions that typically trade at a premium to market price. Integer Announces Strategic Review to Maximize Stockholder Value
• Neutral Sentiment: EPS was essentially flat: reported $1.20 vs. the consensus near $1.19–$1.21, so results were roughly in line with expectations but below last year’s $1.31 — a mixed signal on margin trends. Integer Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Company updated FY?2026 outlook ranges (sales and EPS ranges) and reiterated longer-term targets (expects ~200 bps above-market organic sales growth in 2027), which provides a framework but leaves execution risk. Integer Holdings Corporation Reports First Quarter 2026 Results
• Negative Sentiment: FY?2026 EPS guidance range (5.83–6.40) is below the sell?side consensus (~6.49), which prompted investor concern about near-term profitability and likely capped upside after the print. Integer updated its FY 2026 earnings guidance
• Negative Sentiment: Some outlets reported an initial intraday selloff despite the sales beat — reflecting mixed investor views on the guidance and uncertainty around the strategic review’s timing and outcome. Integer Holdings (NYSE:ITGR) surprises with Q1 CY2026 sales but stock drops

Analyst Ratings Changes

ITGR has been the topic of several research analyst reports. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Wells Fargo & Company raised their target price on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, February 20th. Raymond James Financial restated an “outperform” rating and set a $101.00 target price on shares of Integer in a report on Monday, February 23rd. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Truist Financial raised their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a report on Friday, February 20th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $96.57.

Insider Buying and Selling

In other news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares of the company’s stock, valued at approximately $372,385. The trade was a 15.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Kestra Advisory Services LLC raised its stake in Integer by 0.6% in the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock valued at $1,680,000 after purchasing an additional 136 shares in the last quarter. Orion Porfolio Solutions LLC raised its stake in Integer by 1.4% in the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock valued at $1,200,000 after purchasing an additional 138 shares in the last quarter. Lido Advisors LLC raised its stake in Integer by 5.5% in the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock valued at $226,000 after purchasing an additional 151 shares in the last quarter. Osaic Holdings Inc. raised its stake in Integer by 8.0% in the second quarter. Osaic Holdings Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $312,000 after purchasing an additional 188 shares in the last quarter. Finally, MML Investors Services LLC raised its stake in Integer by 2.4% in the second quarter. MML Investors Services LLC now owns 8,222 shares of the medical equipment provider’s stock valued at $1,011,000 after purchasing an additional 196 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.